切换至 "中华医学电子期刊资源库"

中华肥胖与代谢病电子杂志 ›› 2020, Vol. 06 ›› Issue (04) : 218 -222. doi: 10.3877/cma.j.issn.2095-9605.2020.04.002

所属专题: 总编推荐 文献

论著

腹腔镜袖状胃切除术后肥胖患者肺功能变化与炎症介质及脂肪因子的相关性分析
刘言卫1, 徐岩岩1, 汪泳1,()   
  1. 1. 230000 合肥,安徽医科大学第二附属医院普外科
  • 收稿日期:2020-09-22 出版日期:2020-11-30
  • 通信作者: 汪泳
  • 基金资助:
    安徽医科大学第二附属医院临床研究培育计划项目(2020LCZD07)

Correlation analysis of the relationship between the changes of pulmonary function and inflammatory mediators and adipokines in obese patients after LSG.

Yanwei Liu1, Yanyan Xu1, Yong Wang1,()   

  1. 1. Department of General Surgery, the Second Hospital of Anhui Medical University, Hefei 230000, China
  • Received:2020-09-22 Published:2020-11-30
  • Corresponding author: Yong Wang
  • About author:
    Corresponding author: Wang Yong, Email:
引用本文:

刘言卫, 徐岩岩, 汪泳. 腹腔镜袖状胃切除术后肥胖患者肺功能变化与炎症介质及脂肪因子的相关性分析[J]. 中华肥胖与代谢病电子杂志, 2020, 06(04): 218-222.

Yanwei Liu, Yanyan Xu, Yong Wang. Correlation analysis of the relationship between the changes of pulmonary function and inflammatory mediators and adipokines in obese patients after LSG.[J]. Chinese Journal of Obesity and Metabolic Diseases(Electronic Edition), 2020, 06(04): 218-222.

目的

探究肥胖患者在接受腹腔镜袖状胃切除术(LSG)治疗后6个月时肺功能的变化并评估其与炎症介质及脂肪因子的相关性。

方法

回顾性分析2019年1月至2020年5月在安徽医科大学第二附属医院行LSG手术的116例肥胖患者的病例资料,比较术前及术后6个月患者体重、体质量指数(BMI)、肺功能、脂肪因子及炎症介质等指标的变化,并进一步分析肺功能的变化与炎症介质及脂肪因子之间相关性。本研究共纳入116例行LSG手术的病态肥胖患者,其中男性53例,女性63例,平均年龄(32.52±6.08)岁,BMI(43.35±7.20) kg/m2

结果

术后6个月体重、BMI、颈围、腰围及腹围较术前均明显降低(P<0.05),用力肺活量(FVC)、第一秒用力呼气量(FEV1)、第一秒用力肺活量占用力肺活量的百分比(FEV1/FVC)、最大呼气中期流速(MMEF75/25)等肺功能指标在术后6个月均明显改善(P<0.05)。瘦素(leptin)、肿瘤坏死因子-a(TNF-a)、白细胞介素-6(IL-6)、C-反应蛋白(CRP)水平在术后6个月均明显降低(P<0.05);白细胞介素-10(IL -10)及脂联素(adiponectin)在术后6个月均显著升高(P<0.05)。术前TNF-a、IL-6、CRP、leptin与FEV1呈负相关,adiponectin与FVC呈正相关,而TNF-a、leptin与FVC呈负相关;而在术后6个月,IL-6与FEV1呈负相关;adiponectin与FVC呈显著正相关;而TNF-a与FVC呈负相关。

结论

LSG可显著改善肥胖患者肺功能,肺功能的改善可能与术后脂肪因子及炎症介质的水平变化有关。

Objective

To explore the changes of pulmonary function in obese patients 6 months after treatment with laparoscopic sleeve gastrectomy (LSG), and to evaluate its correlation with adipokines and inflammatory factors.

Methods

A retrospective analysis was made on 116 obese patients who underwent LSG surgery in the second affiliated Hospital of Anhui Medical University from January 2019 to May 2020. The changes of body weight, BMI, pulmonary function, adipose factors and inflammatory mediators were compared before and 6 months after operation, and the correlation between the changes of pulmonary function and inflammatory mediators and adipose factors was further analyzed. A total of 116 obese patients undergoing LSG were included in this study, including 53 males and 63 females, with an average age of (32.52±6.08) years and BMI of (43.35±7.20) kg/m2.

Results

Weight, BMI, neck circumference, waist circumference, and abdominal circumference were significantly lower at 6 months after surgery (P<0.05), and pulmonary function indexes such as FVC, FEV1, FEV1/FVC (%), and MMEF75/25 were significantly lower after surgery (P<0.05). The levels of leptin, TNF-a, IL-6, and CRP were significantly reduced at 6 months after surgery (P<0.05); IL -10 and adiponectin were significantly increased at 6 months after surgery (P<0.05). Before surgery, TNF-a, IL-6, CRP and Leptin were negatively correlated with FEV1, adiponectin was positively correlated with FVC, while TNF-a and leptin was negatively correlated with FVC; and at 6 months after surgery, IL-6 is negatively correlated with FEV1; adiponectin is significantly positively correlated with FVC; and TNF-a is negatively correlated with FVC.

Conclusions

LSG can significantly improve the lung function of obese patients. The improvement of lung function may be related to the changes of postoperative adipose factors and inflammatory mediators.

表1 患者术前术后一般资料及肺功能指标变化(n=116)
图1 术前和术后脂肪因子及炎症介质水平的变化
图2 术前肺功能指标与炎症介质及脂肪因子的相关性分析
图3 术后6个月肺功能指标与炎症介质及脂肪因子的相关性分析
[1]
Andolfi C, Fisichella PM. Epidemiology of Obesity and Associated Comorbidities[J]. J Laparoendosc Adv Surg Tech A, 2018, 28(8): 919-924.
[2]
Peters U, Suratt BT, Bates J, et al. Beyond BMI: Obesity and Lung Disease[J]. Chest, 2018,153(3): 702-709.
[3]
Chen Y, Horne SL, Dosman JA. Body weight and weight gain related to pulmonary function decline in adults: a six year follow up study[J]. Thorax, 1993, 48(4): 375-380.
[4]
Alsumali A, Al-Hawag A, Bairdain S, et al. The impact of bariatric surgery on pulmonary function: a meta-analysis[J]. Surg Obes Relat Dis, 2018, 14(2): 225-236.
[5]
中国医师协会外科医师分会肥胖和糖尿病外科医师委员会. 腹腔镜袖状胃切除术操作指南(2018版)[J/CD]. 中华肥胖与代谢病电子杂志, 2018, 4(4): 196-201.
[6]
Hewitt S, Humerfelt S, Sovik TT, et al. Long-term improvements in pulmonary function 5 years after bariatric surgery[J]. Obes Surg, 2014, 24(5): 705-711.
[7]
Peralta GP, Marcon A, Carsin AE, et al. Body mass index and weight change are associated with adult lung function trajectories: the prospective ECRHS study[J]. Thorax, 2020, 75(4): 313-320.
[8]
Kim SH, Sutherland ER, Gelfand EW. Is there a link between obesity and asthma?[J]. Allergy Asthma Immunol Res, 2014, 6(3): 189-195.
[9]
Oh YM, Jeong BH, Woo SY, et al. Association of plasma adipokines with chronic obstructive pulmonary disease severity and progression[J]. Ann Am Thorac Soc, 2015, 12(7): 1005-1012.
[10]
van den Borst B, Gosker H R, Koster A, et al. The influence of abdominal visceral fat on inflammatory pathways and mortality risk in obstructive lung disease[J]. Am J Clin Nutr, 2012, 96(3): 516-526.
[11]
张蒙, 邓笑伟. 影响肥胖患者肺功能的代谢指标研究进展[J]. 医学综述, 2015, 21(01): 76-78.
[12]
Aronson D, Roterman I, Yigla M, et al. Inverse association between pulmonary function and C-reactive protein in apparently healthy subjects[J]. Am J Respir Crit Care Med, 2006, 174(6): 626-632.
[13]
Sideleva O, Suratt BT, Black KE, et al. Obesity and asthma: an inflammatory disease of adipose tissue not the airway[J]. Am J Respir Crit Care Med, 2012, 186(7): 598-605.
[14]
Luo Y, Liu M. Adiponectin: a versatile player of innate immunity[J]. J Mol Cell Biol, 2016, 8(2): 120-128.
[15]
Vernooy JH, Ubags ND, Brusselle GG, et al. Leptin as regulator of pulmonary immune responses: involvement in respiratory diseases[J]. Pulm Pharmacol Ther, 2013,26(4):464-472.
[16]
姚荣英, 顾璇, 郑玲. 瘦素抵抗肥胖雌性大鼠肺通气功能的损伤研究[J]. 蚌埠医学院学报, 2011, 36(11): 1181-1183.
[17]
Sood A, Shore SA. Adiponectin, Leptin, and Resistin in Asthma: Basic Mechanisms through Population Studies[J]. J Allergy (Cairo), 2013, 2013: 785835.
[18]
Zhu L, Chen X, Chong L, et al. Adiponectin alleviates exacerbation of airway inflammation and oxidative stress in obesity-related asthma mice partly through AMPK signaling pathway[J]. Int Immunopharmacol, 2019, 67: 396-407.
[19]
Da SP, de Mello MT, Cheik NC, et al. Interdisciplinary therapy improves biomarkers profile and lung function in asthmatic obese adolescents[J]. Pediatr Pulmonol, 2012, 47(1): 8-17.
[1] 吴越廷, 周林雨涵, 胡钦, 许华燕, 黄敏, 陈晓勇, 张萌, 李中会, 茹凉, 王秋, 蔡晓唐. 皮质类固醇治疗非卧床杜氏肌营养不良症患儿肺功能与运动功能的纵向研究[J]. 中华妇幼临床医学杂志(电子版), 2024, 20(03): 292-301.
[2] 陈嘉婷, 杜美君, 石冰, 黄汉尧. 母体系统性疾病对新生儿唇腭裂发生的影响[J]. 中华口腔医学研究杂志(电子版), 2024, 18(04): 262-268.
[3] 孟令凯, 李大勇, 王宁, 王桂明, 张炳南, 李若彤, 潘立峰. 袖状胃切除术对肥胖伴2型糖尿病大鼠的作用及机制研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 638-642.
[4] 李猛, 姜腊, 董磊, 吴情, 贾犇黎. 腹腔镜胃袖状切除术治疗肥胖合并2型糖尿病及脂肪胰的临床研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(05): 554-557.
[5] 杨波, 胡旭, 何金艳, 谢铭. 腹腔镜袖状胃切除术管胃固定研究现状[J]. 中华普外科手术学杂志(电子版), 2024, 18(04): 452-455.
[6] 吉顺富, 汤晓燕, 徐进. 腹腔镜近端胃癌根治术中拓展胃后间隙在肥胖患者中的应用研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(04): 393-396.
[7] 张璇, 高杨, 房雅君, 姚艳玲. 保护性机械通气在肺癌胸腔镜肺段切除术中的临床应用[J]. 中华肺部疾病杂志(电子版), 2024, 17(04): 563-567.
[8] 陈冬丽, 邓迎丽, 毕婧. α-干扰素治疗急性呼吸道病毒感染对Th1/Th2平衡及肺功能的影响[J]. 中华肺部疾病杂志(电子版), 2024, 17(04): 590-594.
[9] 王微, 丁霖, 陈茜, 呼延欣, 闫蓓. 综合治疗对慢性阻塞性肺疾病的疗效及转归影响分析[J]. 中华肺部疾病杂志(电子版), 2024, 17(04): 621-624.
[10] 周璇, 谢莉, 邹娟. 尼达尼布对特发性肺纤维化肺功能、肺纤维化程度及PDGF、PGE2、TGF-β1的影响[J]. 中华肺部疾病杂志(电子版), 2024, 17(03): 368-372.
[11] 袁广琴, 朱珠, 林云霞. 胸腺肽联合无创正压通气救治AECOPD并发Ⅱ型呼吸衰竭患者的临床分析[J]. 中华肺部疾病杂志(电子版), 2024, 17(03): 438-441.
[12] 陈先志, 许磊, 冯其柱, 王琦. 布地奈德联合复方异丙托溴铵雾化吸入在老年患者腹腔镜围手术期中的应用[J]. 中华肝脏外科手术学电子杂志, 2024, 13(04): 531-536.
[13] 唐小久, 胡曼, 许必君, 肖亚. 肥胖合并胃食管反流病患者严重程度与其焦虑抑郁及营养状态的相关性研究[J]. 中华消化病与影像杂志(电子版), 2024, 14(04): 360-364.
[14] 闫维, 张二明, 张克, 安欣华, 向平超. 北京市石景山区40岁及以上居民早期慢性阻塞性肺疾病异质性及影响因素分析[J]. 中华临床医师杂志(电子版), 2024, 18(06): 533-540.
[15] 王星, 陈园, 热孜万古丽·乌斯曼, 郭艳英. T2DM、Obesity、NASH、PCOS共同致病因素相关的分子机制[J]. 中华临床医师杂志(电子版), 2024, 18(05): 481-490.
阅读次数
全文


摘要